translating progress with immunotherapies and targeted agents into improved outcomes in tnbc
Published 2 years ago • 256 plays • Length 57:18Download video MP4
Download video MP3
Similar videos
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
1:03:49
making the most of the new era of immuno-oncology in tnbc: essential guidance for surgeons
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
1:04:28
harnessing the immune system in the treatment of triple-negative breast cancer
-
32:10
treatment progress in triple negative breast cancer – improving disparities and outcomes with new...
-
1:31:16
pathologic response after neoadjuvant immunotherapy: facilitating progress in early-stage cancers
-
1:04:09
drs. kuerer & mcarthur discuss the lastest #tnbc updates from #sso2022 - https://bit.ly/3ibs0zk
-
54:37
optimizing patient outcomes in rcc through safe use of immuno-oncology and targeted approaches
-
1:25:29
the era of immuno-oncology in tnbc: implications for breast surgeons
-
21:18
treatment progress in triple negative breast cancer – improving disparities and outcomes with new...
-
31:11
treatment progress in tnbc – improving disparities and outcomes with new approaches
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
1:28:17
getting personal with advanced btc
-
1:30:40
calibrating hcc care: delivering effective tx with modern immunotherapy and targeted approaches
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy